These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7567317

  • 21. Concentrations of ceftibuten in bronchial secretions.
    Scaglione F, Triscari F, Demartini G, Arcidiacono M, Cocuzza C, Fraschini F.
    Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.
    Simon MW, Fish DN, Deeter RG.
    Drugs R D; 2002; 3(6):365-73. PubMed ID: 12516939
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.
    Nicolau DP, Sutherland CA, Arguedas A, Dagan R, Pichichero ME.
    Paediatr Drugs; 2007; 9(2):119-23. PubMed ID: 17407367
    [Abstract] [Full Text] [Related]

  • 24. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL, Forbes WP.
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [Abstract] [Full Text] [Related]

  • 25. The penetration of ceftibuten into the respiratory tract.
    Krumpe P, Lin CC, Radwanski E, Cayen MN, Affrime MB.
    Chest; 1999 Aug; 116(2):369-74. PubMed ID: 10453864
    [Abstract] [Full Text] [Related]

  • 26. [Pharmacokinetics and clinical studies of flomoxef in the pediatric field].
    Motohiro T, Oda K, Aramaki M, Kawakami A, Tanaka K, Koga T, Shimada Y, Tomita S, Sakata Y, Fujimoto T.
    Jpn J Antibiot; 1987 Aug; 40(8):1515-34. PubMed ID: 3430727
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacokinetic studies on oral antibiotics in pediatrics. V. A pharmacokinetic study on cefdinir in pediatrics].
    Nakamura H, Iwai N.
    Jpn J Antibiot; 1992 Jan; 45(1):12-27. PubMed ID: 1495194
    [Abstract] [Full Text] [Related]

  • 28. [Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics].
    Motohiro T, Handa S, Yamada S, Oki S, Tsumura N, Yoshinaga Y, Aramaki M, Shimada Y, Kawakami A, Koga T.
    Jpn J Antibiot; 1990 Oct; 43(10):1813-35. PubMed ID: 2086819
    [Abstract] [Full Text] [Related]

  • 29. Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Members of the Ceftibuten Otitis Media United States Study Group.
    Mclinn SE, Mccarty JM, Perrotta R, Pichichero ME, Reidenberg BE.
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S108-14. PubMed ID: 7567310
    [Abstract] [Full Text] [Related]

  • 30. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA, Stoeckel K.
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [Abstract] [Full Text] [Related]

  • 31. [Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics].
    Iwai N, Nakamura H, Miyazu M, Watanabe Y.
    Jpn J Antibiot; 1991 Oct; 44(10):1119-33. PubMed ID: 1762168
    [Abstract] [Full Text] [Related]

  • 32. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Wiseman LR, Balfour JA.
    Drugs; 1994 May; 47(5):784-808. PubMed ID: 7520858
    [Abstract] [Full Text] [Related]

  • 33. Comparative bioavailability of loracarbef chewable tablet vs. oral suspension in children.
    Abdel-Rahman SM, Blowey DL, Kauffmann RE, Kearns GL.
    Pediatr Infect Dis J; 1998 Dec; 17(12):1171-3. PubMed ID: 9877373
    [No Abstract] [Full Text] [Related]

  • 34. [Overall clinical evaluation of cefprozil against infections in pediatric fields. Pediatric Study Group for Cefprozil].
    Fujii R, Meguro H, Tajima T, Shiraishi H, Abe T, Nakazawa S, Sato H, Niinou K, Matsumoto K, Sunakawa K.
    Jpn J Antibiot; 1992 Nov; 45(11):1592-608. PubMed ID: 1494240
    [Abstract] [Full Text] [Related]

  • 35. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and tissue penetration of ceftibuten.
    Wise R, Nye K, O'Neill P, Wostenholme M, Andrews JM.
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1053-5. PubMed ID: 2393265
    [Abstract] [Full Text] [Related]

  • 37. Determination of a cephalosporin antibiotic, ceftibuten, in human plasma with column-switching high-performance liquid chromatography with ultraviolet detection.
    Pan HT, Kumari P, Lim J, Lin CC.
    J Pharm Sci; 1992 Jul; 81(7):663-6. PubMed ID: 1403700
    [Abstract] [Full Text] [Related]

  • 38. Ceftibuten concentrations in human tonsillar tissue.
    Scaglione F, Pintucci JP, Demartini G, Dugnani S.
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):940-3. PubMed ID: 9031878
    [Abstract] [Full Text] [Related]

  • 39. Multiple-dose pharmacokinetics and safety of an ibuprofen-pseudoephedrine cold suspension in children.
    Gelotte CK, Prior MJ, Pendley C, Zimmerman B, Lavins BJ.
    Clin Pediatr (Phila); 2010 Jul; 49(7):678-85. PubMed ID: 20356918
    [Abstract] [Full Text] [Related]

  • 40. Oral ceftibuten switch therapy for acute pyelonephritis in children.
    Vilaichone A, Watana D, Chaiwatanarat T.
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S61-7. PubMed ID: 11529382
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.